Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases

Abstract

In this single institution study, SBRT to oligometastatic lymph nodes provided excellent LC and a moderate chemotherapy-free interval with minimal toxicities. Disease progression remains prominent in these patients and larger studies are warranted to identify those who benefit most from SBRT.